Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfanilamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 16/20 | 0.68 |
| ▸ | CA9 | Q16790 | 14/20 | 0.68 |
| ▸ | CA1 | P00915 | 13/20 | 0.68 |
| ▸ | CA12 | O43570 | 12/20 | 0.68 |
| ▸ | CA7 | P43166 | 8/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.68 |
| ▸ | CA6 | P23280 | 4/20 | 0.68 |
| ▸ | CA5A | P35218 | 4/20 | 0.68 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | CA4 | P22748 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfanilamide SCHEMBL2215151 | 0.85 | CA2 (0.77) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL419065 | 0.83 | CA2 (0.74) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL28552204 | 0.83 | CA2 (0.61) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL8197658 | 0.83 | CA2 (0.81) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL4188099 | 0.83 | CA2 (0.90) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL31544839 | 0.82 | CA2 (1.00) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL2798899 | 0.82 | CA2 (1.00) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL740 | 0.82 | CA2 (1.00) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL30659052 | 0.82 | CA2 (1.00) | CA2CA9CA1CA12CA7 | |
| Sulfanilamide SCHEMBL8079221 | 0.82 | CA2 (0.59) | CA2CA9CA1CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108184854-A | A kind of bactericidal composition and its application containing cyazofamid | 成都格瑞赛斯科技有限公司 | 2018-06-22 | — | — | CN | claimed |
| CN-108041063-A | A kind of bactericidal composition of containing cymoxanil and its application | 成都格瑞赛斯科技有限公司 | 2018-05-18 | — | — | CN | claimed |
| CN-107232217-A | One group of microbicide compositions and its application | 泰安市农业科学研究院 | 2017-10-10 | — | — | CN | claimed |
| CN-102711453-B | Stable oil-in-water emulsions | DOW AGROSCIENCES LLC | 2014-07-16 | — | — | CN | claimed |
| EP-1844201-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE RESPONSE MODIFIERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-10-17 | — | — | EP | claimed |
| WO-2006084251-A2 | AQUEOUS GEL FORMULATIONS CONTAINING IMMUNE REPONSE MODIFIERS | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| EP-0089290-B1 | CONJUGATES OF HAPTENES AND MURAMYL PEPTIDES HAVING AN IMMUNOGENIC ACTIVITY, AND COMPOSITIONS CONTAINING THEM | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1989-06-14 | — | — | EP | claimed |
| US-4639512-A | Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) | 1987-01-27 | — | — | US | claimed |
| EP-0089290-A1 | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-09-21 | — | — | EP | claimed |
| US-4022878-A | NATIVE HOMOLOGOUS HAPTEN OR ANTIGEN | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-05-10 | — | — | US | claimed |
| CN-118103059-A | Self-assembled nanoparticles based on amphiphilic peptides | 巴林萨斯生物疗法北美公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-3551626-B1 | BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023070132-A1 | IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER | OHIO STATE INNOVATION FOUNDATION (US) | 2023-04-27 | — | — | WO | disclosed |
| CN-211445576-U | Synthetic process unit of p-acetamidophenyl ethyl ether bulk drug | 李宾 | 2020-09-08 | — | — | CN | disclosed |
| CN-105126072-B | Compositions for stimulating innate immune resistance to pathogens in mammals | 德克萨斯大学系统董事会 | 2020-05-15 | — | — | CN | disclosed |
| US-4639512-A | Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (FR) | 1987-01-27 | — | — | US | disclosed |
| US-4628037-A | Binding assays employing magnetic particles | ADVANCED MAGNETICS, INC. (US) | 1986-12-09 | — | — | US | disclosed |
| US-4554088-A | BIOAFFINITY ADSORBENT DOUPLED TO POLYSILOXANE COATING | ADVANCED MAGNETICS INC. (US) | 1985-11-19 | — | — | US | disclosed |
| EP-0125995-A2 | Magnetic particles for use in separations | ADVANCED MAGNETICS, INC. (US) | 1984-11-21 | — | — | EP | disclosed |
| EP-0089290-A1 | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-09-21 | — | — | EP | disclosed |